Article
Genetic variant in visfatin gene promoter contributes to reduced risk of hepatocellular carcinoma in a Chinese population.
Oncotarget - 22 Nov 2016
Wu Zhitong, Sun Yifan, Huang Yiyong, Zhu Shengbo, Feng Yi, Ye Huifen, Liu Chunming, Tang Shifu
Abstract excerpt
Knowledge on the role of gene variants in the visfatin promoter region in the hepatitis B virus (HBV)-related liver diseases is limited. In this study, we genotyped two potentially functional single nucleotide polymorphisms (SNPs) in the visfatin promoter region, -1535C>T (rs61330082) and -3187G>A (rs11977021), in 120 HBV-related chronic hepatitis B (CHB) patients, 140 HBV-related liver cirrhosis (HBV-LC)...
Topics
- Asian People
- Carcinoma, Hepatocellular
- Case-Control Studies
- Cytokines
- Female
- Genetic Predisposition to Disease
